Company Profile

deCODE Biostructures Group (AKA: Emerald BioStructures)
Profile last edited on: 4/3/19      CAGE:       UEI:

Business Identifier: Proteomics
Year Founded
1997
First Award
1998
Latest Award
2002
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

7865 NE Day Road West
Bainbridge Island, WA 98110
Location: Single
Congr. District: 06
County: Kitsap

Public Profile

Originally acquired in May 2000 by Medichem Research, IL -- itself an SBIR firm -- Emerald BioStructures offered products and services in protein X-ray crystallography, specializing in the area of protein crystallization. In March 2002, Medichem was itself acquired by the Icelandic firm deCODE genetics, Inc. Being foreign owned and outside the size limits of SBIR, neither firm is now program eligible

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
10-14

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2002 1 NIH $138,961
Project Title: Automated Protein Crystal Growth in Lipidic Cubic Phase
2002 2 NIH $1,542,444
Project Title: Anticancer Drug Design Targeting Human Topoisomerase I
2002 2 NIH $710,860
Project Title: Tools For Combinatorial Macromolecular Crystallization
2000 2 NIH $592,778
Project Title: Anticancer Compounds Designed to Poison Topoisomerase I
2000 1 NIH $230,608
Project Title: High-Throughput Crystallization of Proteins

Key People / Management

  Lance J Stewart -- President

  Hidong Kim

  Peter Nollert

Company News

There are no news available.